iLoF

is a digital health company founded in 2019, based in the United Kingdom. The company's slogan "Using AI and Photonics to enable a new era of personalized, precision medicine" encapsulates its mission of revolutionizing drug discovery and development. iLoF employs advanced AI and Photonics to amass significant data for creating a digital library of biomarkers and biological profiles, with the goal of hastening the delivery of personalized treatments to patients. Recognized by CB Insights as one of the top Digital Health companies and acknowledged by the Financial Times as a Transformational Business in Healthcare, iLoF has attracted support from notable institutions such as Microsoft Ventures, Mayfield, and Oxford University. The company has also garnered attention from industry publications including Tech Crunch, Wired, and Sifted as a rising star in AI-Driven Drug Discovery, Health Screening & Data Analytics. Although the last investment details are not specified, iLoF's innovative approach has piqued the interest of potential investors.